AC018630.1 | Uncharacterized protein | Predicted membrane proteins
| | | | | Tissue enhanced |
AC105020.1 | Uncharacterized protein; cDNA FLJ12988 fis, clone NT2RP3000080 | | | | | | Tissue enhanced |
AC114494.1 | HCG1787699; Uncharacterized protein | | | | | | Tissue enhanced |
AC114546.1 | HCG37415; PRO1914; Uncharacterized protein | | | | | | Tissue enhanced |
ACSBG1 | Acyl-CoA synthetase bubblegum family member 1 | Enzymes
| | | | | Tissue enhanced |
AJUBA | Ajuba LIM protein | Cancer-related genes
| | | | | Tissue enhanced |
AL162407.1 | CDNA FLJ20147 fis, clone COL07954; HCG1781466; Uncharacterized protein | Predicted membrane proteins
| | | | | Tissue enhanced |
AL353354.2 | | Predicted secreted proteins
| | | | | Tissue enhanced |
AL353791.1 | | | | | | | Tissue enhanced |
AL359736.1 | Protein PCOTH isoform 1 | | | | | | Tissue enhanced |
AL591684.1 | Protein LOC100996760 | | | | | | Tissue enhanced |
AL603965.1 | Protein LOC100996760 | | | | | | Tissue enhanced |
ALDH3B2 | Aldehyde dehydrogenase 3 family, member B2 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ALS2CL | ALS2 C-terminal like | | | | | | Tissue enhanced |
ANKK1 | Ankyrin repeat and kinase domain containing 1 | Enzymes
| | | | | Tissue enhanced |
ANKRD35 | Ankyrin repeat domain 35 | | | | | | Tissue enhanced |
ANO9 | Anoctamin 9 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANXA8 | Annexin A8 | | | | | | Tissue enhanced |
ANXA8L1 | Annexin A8-like 1 | | | | | | Tissue enhanced |
ANXA8L2 | Annexin A8-like 2 | | | | | | Tissue enhanced |
APCDD1 | Adenomatosis polyposis coli down-regulated 1 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ARHGEF4 | Rho guanine nucleotide exchange factor (GEF) 4 | Plasma proteins
| | | | | Tissue enhanced |
ARSF | Arylsulfatase F | Predicted membrane proteins
| | | | | Tissue enhanced |
ASIP | Agouti signaling protein | Predicted secreted proteins
| | | | | Tissue enhanced |
ATG9B | Autophagy related 9B | Predicted membrane proteins
| | | | | Tissue enhanced |
ATP13A5 | ATPase type 13A5 | Predicted membrane proteins
| | | | | Tissue enhanced |
BCL11B | B-cell CLL/lymphoma 11B (zinc finger protein) | Cancer-related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
BCL2L10 | BCL2-like 10 (apoptosis facilitator) | Mitochondrial proteins Predicted membrane proteins
| | | | | Tissue enhanced |
BTBD16 | BTB (POZ) domain containing 16 | | | | | | Tissue enhanced |
BX088651.1 | LOC100126582 protein; Uncharacterized protein | Predicted membrane proteins
| | | | | Tissue enhanced |
C17orf100 | Chromosome 17 open reading frame 100 | | | | | | Tissue enhanced |
C1QTNF9B | C1q and tumor necrosis factor related protein 9B | Predicted secreted proteins
| | | | | Tissue enhanced |
C2orf54 | Chromosome 2 open reading frame 54 | | | | | | Tissue enhanced |
C6orf25 | Chromosome 6 open reading frame 25 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
C6ORF50 | | Predicted membrane proteins
| | | | | Tissue enhanced |
CACNB4 | Calcium channel, voltage-dependent, beta 4 subunit | Disease related genes FDA approved drug targets Plasma proteins Transporters
| | | | | Tissue enhanced |
CAMSAP3 | Calmodulin regulated spectrin-associated protein family, member 3 | Plasma proteins
| | | | | Tissue enhanced |
CARD14 | Caspase recruitment domain family, member 14 | Disease related genes
| | | | | Tissue enhanced |
CARD17 | Caspase recruitment domain family, member 17 | | | | | | Tissue enhanced |
CCER2 | Coiled-coil glutamate-rich protein 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
CD1A | CD1a molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CDC42BPG | CDC42 binding protein kinase gamma (DMPK-like) | Enzymes
| | | | | Tissue enhanced |
CDH22 | Cadherin 22, type 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
CDH3 | Cadherin 3, type 1, P-cadherin (placental) | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CELSR1 | Cadherin, EGF LAG seven-pass G-type receptor 1 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
CELSR2 | Cadherin, EGF LAG seven-pass G-type receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CGB7 | Chorionic gonadotropin, beta polypeptide 7 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CLCA2 | Chloride channel accessory 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
CLDN1 | Claudin 1 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
COL6A5 | Collagen, type VI, alpha 5 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |